Efficacy of intravenous immunoglobulin treatment in immunocompromised children with H1N1 influenza: A clinical observation

Clinical Respiratory Journal

Volumn 10, Issue 2, 2016, Pages 223-230

  Gokturk, Bahar ^a   Pekcan, Sevgi ^b   Guner, Sukru Nail ^b   Artac, Hasibe ^c   Keles, Sevgi ^b   Kirac, Mine ^b   Reisli, Ismail ^b  

^a KONYA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^c SELCUK UNIVERSITY   (Turkey)

Author keywords

Child; H1N1 influenza; Immunodeficiency; Intravenous immunoglobulin G

Indexed keywords

IMMUNOGLOBULIN G; NITROGEN; OSELTAMIVIR; IMMUNOGLOBULIN;

ADENOSINE DEAMINASE DEFICIENCY; ADOLESCENT; ADULT; ARTICLE; BRONCHIECTASIS; CAUSE OF DEATH; CHEDIAK HIGASHI SYNDROME; CHILD; CONTROLLED STUDY; COUGHING; DISEASE DURATION; DRUG EFFICACY; FATIGUE; FEMALE; FEVER; HOSPITALIZATION; HUMAN; HUMAN CELL; HYPER IGE SYNDROME; IMMUNOCOMPROMIZED PATIENT; IMMUNOGLOBULIN DEFICIENCY; INFLUENZA A (H1N1); INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; LYMPHOCYTE; MALE; MORTALITY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE; VOMITING; X LINKED AGAMMAGLOBULINEMIA; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; INFANT; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MEXICO; NEWBORN; PRESCHOOL CHILD; TREATMENT OUTCOME; VIROLOGY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MEXICO; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84959264477     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12209     Document Type: Article

References (38)

1. Garcia-Garcia J, Ramos C. Influenza, an existing public health problem. Salud Publica Mex. 2006;48: 244-267.
2. Richard SA, Sugaya N, Simonsen L, Miller MA, Viboud C. A comparative study of the 1918-1920 influenza pandemic in Japan, USA and UK: mortality impact and implications for pandemic planning. Epidemiol Infect. 2009;137: 1062-1072.
3. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic vs epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178: 53-60.
4. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, etal. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;18: 2605-2615.
5. The Ministry of Health of Turkey. Pandemic influenza A (H1N1) bulletin. Available at: http://www.grip.gov.tr/index.php?option=com_content&view=article&id=854:19012010-tarihli-acklama-saat-1800-&catid=112:haberler&Itemid=539 (accessed 19 January 2010).
6. Collins SD. Age and sex incidence of influenza and pneumonia morbidity and mortality in the epidemic of 1928-1929 with comparative data for the epidemic of 1918-1919. Public Health Rep. 1931;33: 1909-1937.
7. World Health Organization. Pandemic (H1N1) 2009 - Update 94. Geneva, World Health Organization Website, 2010. Available at: http://www.who.int/csr/don/2010_04_01/en/index.html (accessed 9 April 2010)
8. Centers for Disease Control and Prevention. CDC Estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States, April 2009-February 13, 2010. Atlanta, Centers for Disease Control and Prevention Website, 2010. Available at: http://www.flu.gov/individualfamily/about/h1n1/estimates_2009_h1n1.html (accessed 9 April 2010).
9. Aksu G, Genel F, Koturoğlu G, Kurugöl Z, Kütükçüler N. Serum immunoglobulin (IgG, IgM, IgA) and IgG subclass concentrations in healthy children: a study using nephelometric technique. Turk J Pediatr. 2006;48: 19-24.
10. Bettinger JA, Sauvé LJ, Scheifele DW, etal. Pandemic influenza in Canadian children: a summary of hospitalized pediatric cases. Vaccine. 2010;28: 3180-3184.
11. Çiftçi E, Tuygun N, Özdemir H, etal. Clinical and epidemiological features of Turkish children with 2009 pandemic influenza A (H1N1) infection: experience from multiple tertiary paediatric centres in Turkey. Scand J Infect Dis. 2011;43: 923-929.
12. Park YJ, Jin JY, Yang HJ, etal. Clinical characteristics of 2009 pandemic influenza A (H1N1) infection in children and the performance of rapid antigen test. Korean J Pediatr. 2011;54: 405-408.
13. Farooq O, Faden HS, Cohen ME, etal. Neurologic complications of 2009 influenza-A H1N1 infection in children. J Child Neurol. 2012;27: 431-438.
14. Lyon JB, Remigio C, Milligan T, Deline C. Acute necrotizing encephalopathy in a child with H1N1 influenza infection. Pediatr Radiol. 2010;40: 200-205.
15. Randolph AG, Vaughn F, Sullivan R, etal. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics. 2011;128: 1450-1458.
16. O'Riordan S, Barton M, Yau Y, etal. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ. 2010;182: 39-44.
17. Owayed AF, Husain EH, Al-Khabaz A, etal. Epidemiology and clinical presentation of pandemic influenza A (H1N1) among hospitalized children in Kuwait. Med Princ Pract. 2012;21: 254-258.
18. Yunoki M, Kubota-Koketsu R, Urayama T, etal. Significant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1. Br J Haematol. 2010;148: 953-955.
19. Gordon CL, Johnson PD, Permezel M, etal. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis. 2010;50: 672-678.
20. Chong JL, Sapari S, Kuan YC. A case of acute respiratory distress syndrome associated with novel H1N1 treated with intravenous immunoglobulin G. J Microbiol Immunol Infect. 2011;44: 319-322.
21. Morishima T. Treatment of influenza-associated encephalopathy. Nihon Rinsho. 2003;61: 2006-2012.
22. Hagiwara S, Iwasaka H, Hasegawa A, Asai N, Noguchi T. High dose intravenous immunoglobulin G improves systemic inflammation in a rat model of CLP-induced sepsis. Intensive Care Med. 2008;34: 1812-1819.
23. Hung IF, To KK, Lee CK, etal. Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection. Chest. 2013;144: 464-473.
24. Jain S, Kamimoto L, Bramley AM, etal. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361: 1935-1944.
25. Thompson WW, Shay DK, Weintraub E, etal. Influenza-associated hospitalizations in the United States. JAMA. 2004;292: 1333-1340.
26. Hancock K, Veguilla V, Lu X, etal. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361: 1945-1952.
27. Hong DK, Tremoulet AH, Burns JC, Lewis DB. Cross-reactive neutralizing antibody against pandemic 2009 H1N1 influenza A virus in intravenous immunoglobulin preparations. Pediatr Infect Dis J. 2011;30: 67-69.
28. Luke TC, Kilbane EM, Jackson JL, Hoffman SL. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med. 2006;145: 599-609.
29. Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med. 2007;357: 1450-1451.
30. Palladino G, Mozdzanowska K, Washko G, Gerhard W. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol. 1995;69: 2075-2081.
31. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients-Seattle, Washington. MMWR. 2009;58: 893-896.
32. Nimmerjahn F, Ravetch JV. The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med. 2007;204: 11-15.
33. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 2001;291: 484-486.
34. Bayry J, Thirion M, Misra N, etal. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Neurol Sci. 2003;24: 217-221.
35. Mansour MH. 2009 H1N1 influenza A in children: a descriptive clinical study. Ann Saudi Med. 2012;32: 59-63.
36. Rodríguez A, Alvarez-Rocha L, Sirvent JM, etal. Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit. Med Intensiva. 2012;36: 103-137.
37. Sharon N, Talnir R, Lavid O, etal. Transient lymphopenia and neutropenia: pediatric influenza A/H1N1 infection in a primary hospital in Israel. Isr Med Assoc J. 2011;13: 408-412.
38. Hage JE, Petelin A, Cunha BA. Before influenza tests results are available, can droplet precautions be instituted if influenza is suggested by leukopenia, relative lymphopenia, or thrombocytopenia? Am J Infect Control. 2011;39: 619-621.